Founded in 2012, Norgine Ventures invests in debt financing, post-IPO debt, and venture rounds for innovative healthcare and life sciences companies in Europe and the US. Backed by Norgine, a European healthcare company with over 110 years of experience, Norgine Ventures has made 15 investments to date, including in specialty pharma, diagnostic, and medical device companies. They aim to foster innovation in the healthcare sector and achieve financial returns. Notable portfolio companies include PathoQuest, Caresyntax, and SpineGuard.